|
Market Closed -
Nasdaq
16:00:00 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 3.130 USD | -10.57% |
|
-22.33% | +131.85% |
| Market Cap | 296M 257M 243M 220M 412M 28.42B 416M 2.9B 1.11B 14.41B 1.11B 1.09B 45.97B | P/E 2026 * |
-1.43x | P/E 2027 * | -1.61x |
|---|---|---|---|---|---|
| Enterprise Value | 91.77M 79.49M 75.17M 68.05M 128M 8.8B 129M 897M 345M 4.46B 345M 337M 14.24B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.58x |
| Free-Float |
78.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ZNTL | Delayed | |
CBOE
| ZNTL | Real-time |
Last Transcript: Zentalis Pharmaceuticals, Inc.
| 1 day | -10.57% | ||
| 1 week | -22.33% | ||
| Current month | -16.76% | ||
| 1 month | -12.08% | ||
| 3 months | -17.20% | ||
| 6 months | +15.50% | ||
| Current year | +131.85% |
| 1 week | 3.12 |  | 3.76 |
| 1 month | 3.12 | | 4.19 |
| Current year | 1.32 | | 6.95 |
| 1 year | 1.21 | | 6.95 |
| 3 years | 1.01 | | 23.52 |
| 5 years | 1.01 | | 87.19 |
| 10 years | 1.01 | | 87.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 62 | 2024-11-12 |
| Director of Finance/CFO | - | 2024-11-12 | |
Ingmar Bruns
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-11-12 |
| Director | Title | Age | Since |
|---|---|---|---|
David Johnson
CHM | Chairman | 61 | 2022-05-15 |
Enoch Kariuki
BRD | Director/Board Member | 44 | 2021-02-08 |
Jan Skvarka
BRD | Director/Board Member | 59 | 2022-09-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/14/26 | Buy | 4,335,000 | 4.5791% | |||
| 5/26/26 | Free | Director | 114,200 | 0.1604% | ||
| 2/6/26 | Sell | Chief Technology Officer | 3,297 | 0.0046% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.57% | -22.33% | +115.86% | -86.63% | 331M | |
| -1.38% | +2.23% | +48.54% | +100.96% | 70.24B | |
| -1.04% | -0.81% | +34.61% | +75.16% | 62.63B | |
| -4.29% | -3.98% | -16.22% | +350.66% | 27.36B | |
| +0.16% | -0.16% | +26.73% | +12.12% | 25.71B | |
| -2.20% | -2.00% | -1.22% | -14.48% | 24.83B | |
| +1.61% | -0.69% | +20.85% | -19.42% | 19.52B | |
| +1.26% | -14.23% | +170.04% | +298.75% | 15.51B | |
| -3.91% | -5.25% | -9.16% | +485.32% | 14.66B | |
| -5.54% | +0.69% | -8.13% | +830.48% | 14.69B | |
| Average | -2.59% | -2.43% | +38.19% | +203.29% | 27.55B | |
| Weighted average by Cap. | -1.53% | -0.66% | +31.29% | +162.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 16.38M 14.19M 13.41M 12.14M 22.79M 1.57B 22.97M 160M 61.59M 797M 61.52M 60.16M 2.54B |
| Net income | -165M -143M -135M -122M -229M -15.79B -231M -1.61B -619M -8.01B -618M -605M -25.53B | -169M -146M -138M -125M -235M -16.2B -237M -1.65B -635M -8.22B -635M -620M -26.2B |
| Net Debt | -205M -177M -168M -152M -285M -19.62B -287M -2B -769M -9.95B -768M -751M -31.73B | -139M -121M -114M -103M -194M -13.38B -196M -1.36B -524M -6.78B -524M -512M -21.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-15 | US$3.130 | -10.57% | 1,398,605 |
| 26-09-14 | US$3.500 | -0.28% | 750,363 |
| 26-09-11 | US$3.510 | -2.23% | 787,858 |
| 26-09-10 | US$3.590 | -5.53% | 864,208 |
| 26-09-09 | US$3.800 | -5.71% | 782,547 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZNTL Stock
Select your edition
All financial news and data tailored to specific country editions
